These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37253978)

  • 1. Need to continue or discontinue RAS inhibitors as CKD stage advances? Any alternative?
    Fujimoto D; Kuwabara T; Mukoyama M
    Hypertens Res; 2023 Aug; 46(8):2048-2050. PubMed ID: 37253978
    [No Abstract]   [Full Text] [Related]  

  • 2. The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients with Advanced Chronic Kidney Disease.
    Oh YJ; Kim SM; Shin BC; Kim HL; Chung JH; Kim AJ; Ro H; Chang JH; Lee HH; Chung W; Lee C; Jung JY
    PLoS One; 2017; 12(1):e0170874. PubMed ID: 28122064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.
    Lin CC; Wu YT; Yang WC; Tsai MJ; Liu JS; Yang CY; Li SY; Ou SM; Tarng DC; Hsu CC
    PLoS One; 2017; 12(12):e0189126. PubMed ID: 29216260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should we discontinue RAS-inhibitor therapy in patients with advanced CKD?
    Georgianos PI; Vaios V; Divani M; Liakopoulos V
    Expert Opin Pharmacother; 2023 Jun; 24(9):977-980. PubMed ID: 37185138
    [No Abstract]   [Full Text] [Related]  

  • 5. Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?
    Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2020; 40(1):38-45. PubMed ID: 31196659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual RAAS Blockade with Aliskiren in Patients with Severely Impaired Chronic Kidney Disease.
    Rasche FM; Joel C; Ebert T; Frese T; Barinka F; Busch V; Rasche WG; Lindner TH; Schneider J; Schiekofer S
    Exp Clin Endocrinol Diabetes; 2018 Jan; 126(1):39-52. PubMed ID: 28449154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease.
    Bhandari S; Mehta S; Khwaja A; Cleland JGF; Ives N; Brettell E; Chadburn M; Cockwell P;
    N Engl J Med; 2022 Dec; 387(22):2021-2032. PubMed ID: 36326117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease.
    Čertíková Chábová V; Kujal P; Škaroupková P; Varňourková Z; Vacková Š; Husková Z; Kikerlová S; Sadowski J; Kompanowska-Jezierska E; Baranowska I; Hwang SH; Hammock BD; Imig JD; Tesař V; Červenka L
    Kidney Blood Press Res; 2018; 43(2):329-349. PubMed ID: 29529602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report.
    Weir MR; Lakkis JI; Jaar B; Rocco MV; Choi MJ; Kramer HJ; Ku E
    Am J Kidney Dis; 2018 Dec; 72(6):873-884. PubMed ID: 30201547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting RAAS blockade in CKD with newer potassium-binding drugs.
    Georgianos PI; Agarwal R
    Kidney Int; 2018 Feb; 93(2):325-334. PubMed ID: 29276100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When should we start and stop ACEi/ARB in paediatric chronic kidney disease?
    Chan EY; Ma AL; Tullus K
    Pediatr Nephrol; 2021 Jul; 36(7):1751-1764. PubMed ID: 33057769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Renin-Angiotensin System Inhibitors in Patients With Chronic Kidney Disease.
    Leon SJ; Tangri N
    Can J Cardiol; 2019 Sep; 35(9):1220-1227. PubMed ID: 31472818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system blockade alone or combined with ET
    Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
    Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underprescription of renin-angiotensin system blockers in moderate to severe chronic kidney disease.
    Shirazian S; Grant CD; Mujeeb S; Sharif S; Kumari P; Bhagat M; Mattana J
    Am J Med Sci; 2015 Jun; 349(6):510-5. PubMed ID: 26030613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of renin-angiotensin system blockade on renal protection in chronic kidney disease patients with hyperkalemia.
    Lee JH; Kwon YE; Park JT; Lee MJ; Oh HJ; Han SH; Kang SW; Choi KH; Yoo TH
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):491-7. PubMed ID: 25143329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-Angiotensin System Inhibition in Advanced CKD.
    Fu EL; Tomlinson LA; Carrero JJ
    N Engl J Med; 2023 Apr; 388(15):1437-1438. PubMed ID: 37043662
    [No Abstract]   [Full Text] [Related]  

  • 18. Renin-Angiotensin System Inhibition in Advanced CKD.
    Sealey JE; Blumenfeld JD
    N Engl J Med; 2023 Apr; 388(15):1437. PubMed ID: 37043661
    [No Abstract]   [Full Text] [Related]  

  • 19. Renin-Angiotensin System Inhibition in Advanced CKD.
    Speth RC
    N Engl J Med; 2023 Apr; 388(15):1436-1437. PubMed ID: 37043660
    [No Abstract]   [Full Text] [Related]  

  • 20. Renin-angiotensin system blockade in patients with chronic kidney disease: benefits, problems in everyday clinical use, and open questions for advanced renal dysfunction.
    Loutradis C; Price A; Ferro CJ; Sarafidis P
    J Hum Hypertens; 2021 Jun; 35(6):499-509. PubMed ID: 33654237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.